Cailin Conner

DocwireNews

Results from a real-world analysis suggested that there may be an association between antihypertensive drugs (eg, potassium-sparing diuretics, calcium channel blockers, losartan) and an increased risk of hyperuricemia, gout, and related adverse events (AEs). The study was published in <a href="https://www.frontiersin.org/articles/10.3389/fphar.2022.1045561/full" target="_blank" rel="noopener">Frontiers in Pharmacology</a>.&ldquo;The role of antihypertensive drugs in inducing hyperuricemia and gout has been a long-term concern in clinical practice,&rdquo; the researchers wrote. &ldquo;We comprehensively evaluated the association between various antihypertensive drugs and the occurrences of hyperuricemia, gout, and related AEs aiming to guide the selection of antihypertensive drugs with a goal of minimizing the risk of hyperuricemia, gout, and related AEs.&rdquo;Researchers used the US Food and Drug Administration Adverse Event Reporting System to perform proportional reporting ratios (PRRs) and a disproportionality analysis. Higher PRRs indicate a stronger association, and a positive signal of disproportionality was defined as PRR &ge;2.Remarking on the results of the study, the authors stated: &ldquo;This study provides the most comprehensive assessment of the association between antihypertensive drugs and the occurrences of hyperuricemia, gout, and related AEs.&rdquo;A total of 46 antihypertensive drugs had positive signals for hyperuricemia, and 66 had positive signals for gout. These hypertensive drugs included diuretics, antihypertensive drugs with central action, &alpha; and &beta; blockers, calcium channel blockers, angiotensin converting enzyme inhibitors, angiotensin II receptor blockers, and vasodilators.The findings of this study have further complemented prior studies that have posited that an association exists between hyperuricemia, gout, and certain types of hypertensive drugs. Regarding the clinical implications of their study, the authors wrote, &ldquo;The recommendation of using losartan or calcium channel blockers for treatment of hypertension in patients with hyperuricemia or gout may not be appropriate.&rdquo;&nbsp;

Jordana Jampel

Positive Preliminary Results From Phase 1 Trial of Dopaminergic Neuron Graft for Parkinson’s Disease

Dementia

Bradley Warady, MD

Joel M. Topf, MD, FACP

2025 Hume Award Winner Is Dedicated to Children’s Care

NKF Spring Clinical Meetings 2025

Distant Brain Metastases in Cutaneous Melanoma May Be Mitigated With Multiple Pathway Inhibitors

Melanoma

Latest News

Some Antihypertensive Drugs May Be Associated With Gout and Adverse Events

Nephrology Times

Results from a real-world analysis suggested that there may be an association between antihypertensive drugs (eg, potassium-sparing diuretics, calcium channel blockers, ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

HER2 Breast Cancer

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe